Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1350957

	registered interest
	date	18/08/2021
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Coronavirus: Vaccination
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to reduce covid-19 vaccine wastage; and what action is taken with unused vaccines.
	tabling member constituency	Birmingham, Ladywood
	tabling member printed	Shabana Mahmood
	uin	40820
	answer	answer is ministerial correction date of answer 06/09/2021 answer text <p>No vaccines should be wasted. All vaccination centres should have a backup list of people in the cohorts currently being vaccinated, who can be called in case doses would be wasted. This is in line with the Enhanced Service Specification for the COVID-19 vaccination programme 2020/21.</p><p>We have put in place robust mitigations throughout the vaccination programme to reduce wastage, manage expiry dates, and avoid vaccine destruction, including, where there is data to support it, looking at the extension of expiry dates.</p><p>The United Kingdom is also one of the largest donors to COVID-19 Vaccines Global Access (COVAX). We will donate at least 100 million surplus doses within the next year, with the first batch of five million already delivered last month.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 06/09/2021 11:43:56 answering member 4113 label Biography information for Nadhim Zahawi
	tabling member	3914 label Biography information for Shabana Mahmood

1351014

	registered interest
	date	18/08/2021
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Travel: Coronavirus
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what discussions his Department has had with its counterpart in Italy in respect of British tourists' entry to Italy whose covid-19 vaccine was manufactured at Serum Institute in India.
	tabling member constituency	Meriden
	tabling member printed	Saqib Bhatti
	uin	41357
	answer	answer is ministerial correction date of answer 07/09/2021 answer text <p>The Serum Institute of India (SII) manufactures both Vaxzevria and Covishield vaccines and both branded vaccines are exactly the same COVID-19 AstraZeneca vaccine. All SII-made doses approved by the United Kingdom (UK) regulator, the Medicines and Healthcare Products Regulatory Agency (MHRA) and administered in the UK were branded as the ’COVID-19 vaccine AstraZeneca’ which is now known commercially as ‘Vaxzevria’.</p><p> </p><p>The government continues to liaise with counterparts in Italy and we are seeking Italian confirmation that they will recognise all AstraZeneca doses administered in the UK. We will ensure that Foreign, Commonwealth and Development Office Travel Advice is kept up to date following any developments.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 07/09/2021 15:10:14 answering member 4113 label Biography information for Nadhim Zahawi
	tabling member	4818 label Biography information for Saqib Bhatti

1351024

	registered interest
	date	18/08/2021
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Coronavirus: Vaccination
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, whether there is a material difference in terms of (a) medical and (b) public health effect between covid-19 vaccines administered overseas and those administered domestically by the NHS.
	tabling member constituency	Plymouth, Sutton and Devonport
	tabling member printed	Luke Pollard
	uin	41241
	answer	answer is ministerial correction date of answer 07/09/2021 answer text <p>Comparisons between vaccines administered across the world are complex due to differences in vaccine trials and monitoring. When a vaccine receives a marketing authorisation or conditional marketing authorisation from a medicines regulator, certain factors or conditions are specified by the national regulator in order to ensure the product is of the highest quality, safety and efficacy for authorisation.</p><p>We are currently considering which regulators and associated vaccines we would be confident to recognise in the United Kingdom.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 07/09/2021 15:06:24 answering member 4113 label Biography information for Nadhim Zahawi
	tabling member	4682 label Biography information for Luke Pollard

1351060

	registered interest
	date	18/08/2021
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Coronavirus: Vaccination
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, whether NHS England plans to use the flu vaccine list to prioritise patients, including those with asthma, for the covid-19 booster vaccination.
	tabling member constituency	Leeds Central
	tabling member printed	Hilary Benn
	uin	40603
	answer	answer is ministerial correction date of answer 06/09/2021 answer text <p>The Joint Committee on Vaccination and Immunisation (JCVI) published interim advice on a potential Covid-19 booster vaccination programme on 30th June 2021 which can be found at the following link:</p><p> </p><p><a href="https://www.gov.uk/government/publications/jcvi-interim-advice-on-a-potential-coronavirus-covid-19-booster-vaccine-programme-for-winter-2021-to-2022/jcvi-interim-advice-potential-covid-19-booster-vaccine-programme-winter-2021-to-2022" target="_blank">https://www.gov.uk/government/publications/jcvi-interim-advice-on-a-potential-coronavirus-covid-19-booster-vaccine-programme-for-winter-2021-to-2022/jcvi-interim-advice-potential-covid-19-booster-vaccine-programme-winter-2021-to-2022</a></p><p> </p><p>The JCVI’s interim advice is that COVID-19 boosters are first offered to the most vulnerable. They advise a two-staged approach, with individuals in Stage 1 offered a COVID-19 booster vaccine as well as a flu vaccine, as soon as possible from September 2021, and individuals in Stage 2 offered a COVID-19 booster vaccine as soon as practicable after Stage 1, with equal emphasis on deployment of the flu vaccine where eligible. Adults aged over 50 years old, and those aged between 16 and 49 who are in an influenza or COVID-19 at-risk group, are included in Stage 2.</p><p>It is important to note that the JCVI’s advice is interim to inform planning, and this may be subject to change.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 06/09/2021 11:45:22 answering member 4113 label Biography information for Nadhim Zahawi
	tabling member	413 label Biography information for Hilary Benn

1351082

	registered interest
	date	18/08/2021
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Influenza: Vaccination
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what recent assessment his Department has made of the effect of the expansion of eligibility for flu vaccination to the over 50s in (a) 2020-21 and (b) 2021-22.
	tabling member constituency	Halton
	tabling member printed	Derek Twigg
	uin	40611
	answer	answer is ministerial correction date of answer 06/09/2021 answer text <p>Last winter, the seasonal flu programme was extended on 1 December 2020 to include those aged 50 to 64 years old who were not in a clinical risk group. Of this group, 35.2% were vaccinated by the end of the season, with an estimated 2,669,568 vaccinations given.</p><p>For the 2021/22 flu season, we will continue to vaccinate all 50 to 64 year olds and will build on record uptake rates from the 20/21 winter. As a result of earlier advice from the Joint Committee on Vaccination and Immunisation and building on lessons learnt, 50 to 64 year olds will be eligible to book their appointment from the beginning of the season to allow more people to get vaccinated earlier.</p><p>In total, over 35 million people will be eligible for a free seasonal flu vaccine this year. The Department is in regular contact with flu vaccine manufacturers to ensure there is a sufficient amount of flu vaccines available to meet uptake ambitions for eligible cohorts.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi grouped question UIN 40613 40614 question first answered 06/09/2021 11:36:34 answering member 4113 label Biography information for Nadhim Zahawi
	tabling member	429 label Biography information for Derek Twigg

1351084

	registered interest
	date	18/08/2021
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Influenza: Vaccination
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps his Department plans to take to improve uptake of the flu vaccination among people aged between 50 and 64 in 2021-22.
	tabling member constituency	Halton
	tabling member printed	Derek Twigg
	uin	40613
	answer	answer is ministerial correction date of answer 06/09/2021 answer text <p>Last winter, the seasonal flu programme was extended on 1 December 2020 to include those aged 50 to 64 years old who were not in a clinical risk group. Of this group, 35.2% were vaccinated by the end of the season, with an estimated 2,669,568 vaccinations given.</p><p>For the 2021/22 flu season, we will continue to vaccinate all 50 to 64 year olds and will build on record uptake rates from the 20/21 winter. As a result of earlier advice from the Joint Committee on Vaccination and Immunisation and building on lessons learnt, 50 to 64 year olds will be eligible to book their appointment from the beginning of the season to allow more people to get vaccinated earlier.</p><p>In total, over 35 million people will be eligible for a free seasonal flu vaccine this year. The Department is in regular contact with flu vaccine manufacturers to ensure there is a sufficient amount of flu vaccines available to meet uptake ambitions for eligible cohorts.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi grouped question UIN 40611 40614 question first answered 06/09/2021 11:36:34 answering member 4113 label Biography information for Nadhim Zahawi
	tabling member	429 label Biography information for Derek Twigg

1351085

	registered interest
	date	18/08/2021
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Influenza: Vaccination
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps his Department (a) has taken and (b) plans to take to improve the uptake of the flu vaccine among people aged 50 to 64 in 2021-22.
	tabling member constituency	Halton
	tabling member printed	Derek Twigg
	uin	40614
	answer	answer is ministerial correction date of answer 06/09/2021 answer text <p>Last winter, the seasonal flu programme was extended on 1 December 2020 to include those aged 50 to 64 years old who were not in a clinical risk group. Of this group, 35.2% were vaccinated by the end of the season, with an estimated 2,669,568 vaccinations given.</p><p>For the 2021/22 flu season, we will continue to vaccinate all 50 to 64 year olds and will build on record uptake rates from the 20/21 winter. As a result of earlier advice from the Joint Committee on Vaccination and Immunisation and building on lessons learnt, 50 to 64 year olds will be eligible to book their appointment from the beginning of the season to allow more people to get vaccinated earlier.</p><p>In total, over 35 million people will be eligible for a free seasonal flu vaccine this year. The Department is in regular contact with flu vaccine manufacturers to ensure there is a sufficient amount of flu vaccines available to meet uptake ambitions for eligible cohorts.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi grouped question UIN 40611 40613 question first answered 06/09/2021 11:36:34 answering member 4113 label Biography information for Nadhim Zahawi
	tabling member	429 label Biography information for Derek Twigg

1351233

	registered interest
	date	18/08/2021
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Coronavirus: Vaccination
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the risk that routine requests by NHS vaccination centres for NHS and National Insurance numbers may make people who are in the UK illegally less likely to engage with the covid-19 vaccination programme.
	tabling member constituency	Gravesham
	tabling member printed	Adam Holloway
	uin	40751
	answer	answer is ministerial correction date of answer 06/09/2021 answer text <p>No such assessment has been made.</p><p>However, a National Health Service (NHS) number or national insurance number is not needed to make a booking for a COVID-19 vaccine or when attending a vaccination appointment.</p><p>As vaccination against COVID-19 is offered to every eligible adult living in the United Kingdom free of charge, regardless of their immigration status. No immigration checks are needed to receive a COVID-19 vaccination and the NHS is not required to report undocumented migrants to the Home Office.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 06/09/2021 11:45:41 answering member 4113 label Biography information for Nadhim Zahawi
	tabling member	1522 label Biography information for Adam Holloway

1351267

	registered interest
	date	18/08/2021
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Coronavirus: Vaccination
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, whether his Department have taken steps to enable people who participated in the Novavax covid-19 vaccine trials to travel internationally; and what support his Department has provided to the European Medicines Agency for the registration of that vaccine.
	tabling member constituency	Henley
	tabling member printed	John Howell
	uin	40817
	answer	answer is ministerial correction date of answer 06/09/2021 answer text <p>The Government continues to make the case that anyone on a COVID-19 vaccine trial should be treated the same in terms of certification as someone who has received a deployed vaccine. Our Chief Medical Officer has written to all of his counterparts in the European Union and European Economic Community on this matter. Discussions are ongoing with other countries, including through groups such as the Group of Seven, the European Commission and the World Health Organisation to shape the approach taken around the world to sharing health status for travel.</p><p>The Vaccines Taskforce and the Medicines and Healthcare products Regulatory Agency (MHRA) are working with Novavax to help ensure their COVID-19 vaccine is authorised as quickly as possible. The decision to license a vaccine is made by the MHRA.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi grouped question UIN 41230 question first answered 06/09/2021 11:43:29 answering member 4113 label Biography information for Nadhim Zahawi
	tabling member	1606 label Biography information for John Howell

1351274

	registered interest
	date	18/08/2021
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Coronavirus: Vaccination
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, with reference to the Joint Committee on Vaccination and Immunisation's (JCVI) recommendation of 4 August 2021 that covid-19 vaccinations should be extended to 16 to 17-year-olds, if he will publish a detailed briefing on the material changes that were provided by the JCVI from their position set out in the JCVI statement on COVID-19 vaccination of children and young people aged 12 to 17 years: 15 July 2021, published on 19 July 2021, that stated that the benefits of universal vaccination in children and young people below the age of 18 do not outweigh the potential risks.
	tabling member constituency	Tynemouth
	tabling member printed	Sir Alan Campbell
	uin	40616
	answer	answer is ministerial correction date of answer 06/09/2021 answer text <p>The minutes of the Joint Committee on Vaccination and Immunisation's (JCVI) meetings in which the COVID-19 vaccination of children and young people were discussed, including those between 15 July and 04 August 2021, will be published on GOV.UK in due course. Any additional briefing will not be published.</p><p>Minutes of the JCVI meetings can be found at the following link:</p><p><a href="https://www.gov.uk/government/groups/joint-committee-on-vaccination-and-immunisation#minutes" target="_blank">https://www.gov.uk/government/groups/joint-committee-on-vaccination-and-immunisation#minutes</a>.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 06/09/2021 12:11:41 answering member 4113 label Biography information for Nadhim Zahawi
	tabling member	529 label Biography information for Sir Alan Campbell